TYPE-2 NEUROFIBROMATOSIS - THE NEED FOR SUPRAREGIONAL CARE

被引:42
|
作者
EVANS, DGR
RAMSDEN, R
HUSON, SM
HARRIS, R
LYE, R
KING, TT
机构
[1] MANCHESTER ROYAL INFIRM, DEPT OTOLARYNGOL, MANCHESTER M13 9WL, LANCS, ENGLAND
[2] CHURCHILL HOSP, DEPT MED GENET, OXFORD OX3 7LJ, ENGLAND
[3] MANCHESTER ROYAL INFIRM, DEPT NEUROSURG, MANCHESTER M13 9WL, LANCS, ENGLAND
[4] LONDON HOSP, DEPT NEUROSURG, LONDON E1 1BB, ENGLAND
来源
JOURNAL OF LARYNGOLOGY AND OTOLOGY | 1993年 / 107卷 / 05期
关键词
NEUROFIBROMATOSIS; CENTRAL; NF2;
D O I
10.1017/S002221510012328X
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
The results of a U.K. study of 145 cases of type 2 neurofibromatosis has shown generally very poor operative results in terms of hearing and facial nerve preservation. Only 9 out of 118 vestibular schwannoma (acoustic neuroma) operations resulted in any clinically detectable hearing preservation and only 32 left the patient with good or normal (House grade I or II) ipsilateral facial nerve function. Although operation is still the definitive treatment of vestibular schwannoma (acoustic neuroma) and may be a lifesaving procedure, it appears that the evidence in favour of early operation is only valid when carried out in highly specialized centres. The special problems of NF2 cases who may go on to develop multiple spinal and cranial tumours making them wheelchair bound and blind as well as deaf warrants a careful experienced approach. Timing of operations may be critical for the enhancement of useful years of quality life. We therefore propose the setting up of a national NF2 register, with the management of cases at a few supraregional centres.
引用
收藏
页码:401 / 406
页数:6
相关论文
共 50 条
  • [31] SOMATIC MUTATIONS IN THE NEUROFIBROMATOSIS TYPE-2 GENE IN SPORADIC MENINGIOMAS
    PAPI, L
    DEVITIS, LR
    VITELLI, F
    AMMANNATI, F
    MENNONNA, P
    MONTALI, E
    BIGOZZI, U
    HUMAN GENETICS, 1995, 95 (03) : 347 - 351
  • [32] Type-2 Neurofibromatosis Patient with Parasagittal Meningioma: A Challenging Airway
    Depuru, Aparna
    Barik, Amiya K.
    Jangra, Kiran
    Panda, Nidhi B.
    JOURNAL OF NEUROANAESTHESIOLOGY AND CRITICAL CARE, 2022, 09 (03) : 195 - 197
  • [33] GENOTYPE-PHENOTYPE CORRELATION IN NEUROFIBROMATOSIS TYPE-2 PATIENTS
    ANDERMANN, AA
    RUTTLEDGE, MH
    RANGARATNAM, S
    ROULEAU, GA
    ANNALS OF NEUROLOGY, 1995, 38 (03) : 537 - 537
  • [34] THE MOUSE HOMOLOG OF THE NEUROFIBROMATOSIS TYPE-2 GENE IS HIGHLY CONSERVED
    CLAUDIO, JO
    MARINEAU, C
    ROULEAU, GA
    HUMAN MOLECULAR GENETICS, 1994, 3 (01) : 185 - 190
  • [35] MANAGEMENT OF INTRACRANIAL NEOPLASMS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE-1 AND TYPE-2
    COHEN, BH
    KAPLAN, AM
    PACKER, RJ
    PEDIATRIC NEUROSURGERY, 1991, 16 (02) : 66 - 72
  • [36] Giant Tumefactive Perivascular Spaces in a Pediatric Patient with Neurofibromatosis Type-2
    Tittle, B.
    Mondok, L.
    ANNALS OF NEUROLOGY, 2019, 86 : S115 - S116
  • [37] THERE IS NO NON-ALLELIC GENETIC-HETEROGENEITY IN NEUROFIBROMATOSIS TYPE-2
    ROULEAU, GA
    NAROD, SA
    FAUCHER, MC
    HAINES, JA
    GUSELLA, JF
    AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 357 - 357
  • [38] PRECISE MAPPING OF THE NEUROFIBROMATOSIS TYPE-2 LOCUS ON CHROMOSOME-22
    ROULEAU, GA
    SEIZINGER, BR
    WERTELECKI, W
    HAINES, JL
    SUPERNEAU, DW
    MARTUZA, RL
    GUSELLA, JF
    CYTOGENETICS AND CELL GENETICS, 1989, 51 (1-4): : 1070 - 1070
  • [39] GERMLINE MUTATIONS IN THE NEUROFIBROMATOSIS TYPE-2 TUMOR-SUPPRESSOR GENE
    BOURN, D
    CARTER, SA
    MASON, S
    EVANS, DGR
    STRACHAN, T
    HUMAN MOLECULAR GENETICS, 1994, 3 (05) : 813 - 816
  • [40] DIAGNOSTIC ISSUES IN A FAMILY WITH LATE-ONSET TYPE-2 NEUROFIBROMATOSIS
    EVANS, DGR
    BOURN, D
    WALLACE, A
    RAMSDEN, RT
    MITCHELL, JD
    STRACHAN, T
    JOURNAL OF MEDICAL GENETICS, 1995, 32 (06) : 470 - 474